Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effects of Isoflavones on Gene-expression (ISO)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Lisette de Groot, Wageningen University
ClinicalTrials.gov Identifier:
NCT01232751
First received: October 21, 2010
Last updated: January 9, 2012
Last verified: January 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2011
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)
No publications provided by Wageningen University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):